Skip navigation

Innovative Models for Elevating Ethics and Integrity Programs

October 20-22, 2020
  • San Francisco, CA

CBI’s Life Sciences West Coast Compliance Congress serves as industry’s “go-to” event for innovative bio/pharmaceutical, medical device and diagnostic compliance and legal professionals. This year is projected to be the most in-depth and impactful yet. Backed by eleven years of high-quality content, this must-attend congress continues to elevate the bar in compliance by convening the brightest minds and most influential stakeholders to converse on the unique compliance challenges and risks, from pre-launch to commercial, within life sciences.

Can’t Miss Content for Local CCOs
and Their Counterparts:

  • Enforcement Trends - Review recent investigations and enforcement actions and identify current areas of greatest risk
  • HCP Interactions – Establish a comprehensive regulatory framework to successfully manage all HCP Interactions
  • Speaker Programs - Master Compliance Through Innovative Initiatives and Best Practices
  • Patient Support –Share best practices for compliant patient interactions
  • Third Party Risk – Uncover red flags and set a tactical plan to enhance third-party oversight
  • Aggregate Spend – Discuss the latest changes in both internal and domestic aggregate spend and transparency reporting
  • Data Privacy and Cyber Security – Strengthen compliance amid the digital revolution

11th Annual Life Sciences West Coast Compliance Congress

Innovative Models for Elevating Ethics and Integrity Programs

CBI’s Life Sciences West Coast Compliance Congress serves as industry’s “go-to” event for innovative bio/pharmaceutical, medical device and diagnostic compliance and legal professionals. This year is projected to be the most in-depth and impactful yet. Backed by eleven years of high-quality content, this must-attend congress continues to elevate the bar in compliance by convening the brightest minds and most influential stakeholders to converse on the unique compliance challenges and risks, from pre-launch to commercial, within life sciences.

Can’t Miss Content for Local CCOs
and Their Counterparts:

  • Enforcement Trends - Review recent investigations and enforcement actions and identify current areas of greatest risk
  • HCP Interactions – Establish a comprehensive regulatory framework to successfully manage all HCP Interactions
  • Speaker Programs - Master Compliance Through Innovative Initiatives and Best Practices
  • Patient Support –Share best practices for compliant patient interactions
  • Third Party Risk – Uncover red flags and set a tactical plan to enhance third-party oversight
  • Aggregate Spend – Discuss the latest changes in both internal and domestic aggregate spend and transparency reporting
  • Data Privacy and Cyber Security – Strengthen compliance amid the digital revolution